JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Retrophin Prices Public Offering of 6,840,000 Shares of Common Stock
-
Esperion Therapeutics (ESPR) Prices 1.75M Common Offering at $100/Share
-
Esperion Therapeutics Prices Public Offering of Common Stock
-
Concert Pharma (CNCE) Plans Common Stock Offering
-
Tekmira Pharma (TKMR) to Offer 6M Common Shares
-
Concert Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Tekmira Announces Proposed Public Offering of Common Shares
-
Tekmira Announces Proposed Public Offering of Common Shares
-
Summit Therapeutics Announces Exercise of Over-Allotment Option
-
JMP Securities Engaged by Procida's 100 Mile Fund
-
Tekmira Pharma (TKMR) Appoints Three New Executives
-
Epizyme (EPZM) 6M Offering Prices at $20.75/Share
-
Tekmira Strengthens Senior Leadership Team With Key Executive Appointments in Corporate Affairs, Chemistry and Biology
-
Tekmira Strengthens Senior Leadership Team With Key Executive Appointments in Corporate Affairs, Chemistry and Biology
-
Flex Pharma Reports Year End 2014 Financial Results
-
JMP Securities Upgrades Charles Schwab Corp. (SCHW) to Market Outperform
-
Form 4 Harvest Capital Credit For: Mar 12 Filed by: JMP SECURITIES LLC
-
Form 4 Harvest Capital Credit For: Mar 12 Filed by: JMP SECURITIES LLC
-
Epizyme (EPZM) to Offer 4.75M Common Shares
-
Horizon Pharma plc Closes Offering of $400 Million of 2.50% Exchangeable Senior Notes, Including Exercise in Full of Option to Purchase Additional Notes
-
Marcus & Millichap (MMI) Lower After Pricing 4M Common Offering at $33.50/Share
-
Marcus & Millichap, Inc. Prices Secondary Offering of 4.0 Million Shares
-
Intra-Cellular Therapies Announces Closing of $130 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
-
Intra-Cellular Therapies Announces Closing of $130 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
-
BioLineRx Closes $28.75 Million Underwritten Public Offering of its American Depositary Shares
-
Summit Therapeutics Announces Closing of Its U.S. Initial Public Offering
-
SteadyMed Ltd. Launches Initial Public Offering
-
GoPro (GPRO) Weakness Related to Apple Event - Analyst
-
Centrify Named to JMP Securities Fast 50 List of Hottest Privately Held Security and Networking Companies
-
JMP Securities Upgrades D.R. Horton (DHI) to Market Outperform
-
JMP Securities Upgrades KB Home (KBH) to Market Outperform
-
JMP Securities Upgrades Ryland Group (RYL) to Market Outperform
-
BioLineRx (BLRX) Prices 12.5M Public Offering at $2/ADS
-
BioLineRx Prices $25 Million Underwritten Public Offering of its American Depositary Shares
-
Horizon Pharma plc Prices Offering of $350 Million of 2.50% Exchangeable Senior Notes
-
Intra-Cellular Therapies (ITCI) Prices 4.75M Offering at $24/Share
-
Intra-Cellular Therapies Prices $114 Million Public Offering of Common Stock
-
Intra-Cellular Therapies Prices $114 Million Public Offering of Common Stock
-
BioLineRx (BLRX) Announces ADS Offering
-
BioLineRx Announces Underwritten Public Offering of its American Depositary Shares
-
Summit Therapeutics (SMMT) IPO Opens Fractionally Higher
-
Apollo Commercial Real Estate Finance (ARI) Prices 10M Common Offering for Proceeds of $170M
-
Apollo Commercial Real Estate Finance, Inc. Announces Pricing of Public Offering of Common Stock
-
Summit Therapeutics Announces Pricing of U.S. Initial Public Offering and Nasdaq Global Market Listing
-
Apollo Commercial Real Estate Finance (ARI) Announces 10M Common Offering
-
Northstar Realty Finance (NRF) Prices 60M Common Offering at $18.65/Share
-
JMP Securities Starts Nexvet Biopharma (NVET) at Market Outperform
-
JMP Securities Upgrades Silver Bay Realty Trust Corp. (SBY) to Market Outperform
-
Actua Executives Invited to Participate at Upcoming Investor Conferences
-
JMP Securities Starts Pandora (P) at Market Perform

